Pharmaceutical deals crucial to offset R&D costs, says GBI Research
|… blockbuster status, pharmaceutical deals are becoming increasingly vital to offset rising R&D costs, says business intelligence provider GBI Research.
… blockbuster status, pharmaceutical deals are becoming increasingly vital to offset rising R&D costs, says business intelligence provider GBI Research.